Actively Recruiting
Early-access Avacopan in Real-world ANCA-associated Vasculitis
Led by Leiden University Medical Center · Updated on 2025-01-27
100
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
Sponsors
L
Leiden University Medical Center
Lead Sponsor
U
University of Udine
Collaborating Sponsor
AI-Summary
What this Trial Is About
The current study proposal aims to investigate the clinical practice variation of the initial use of avacopan for AAV patients in Europe. The study will describe patient characteristics and organ-specific clinical benefit of avacopan treatment in a unique, first-experience cohort of AAV patients. By studying the clinical practice variation of first-experience avacopan treatment, this study will be uniquely positioned to identify pivotal issues on the real-life implementation of avacopan treatment. These observational data can ultimately serve to address current knowledge gaps on avacopan treatment in AAV patients, improve the care and drug-access for AAV patients with avacopan treatment and generate new areas of research.
CONDITIONS
Official Title
Early-access Avacopan in Real-world ANCA-associated Vasculitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Established diagnosis of granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)
- Initiation of treatment with avacopan
- Provided informed consent for use of medical data
You will not qualify if you...
- No active ANCA-associated vasculitis disease activity supported by clinical measures or assessments
- Participant is younger than 16 years old
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Leiden University Medical Center
Leiden, Netherlands
Actively Recruiting
Research Team
Y
Y.K.O. Teng, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here